Author: Aghili, Rokhsareh; Honardoost, Maryam; Khamseh, Mohammad E
Title: COVID-19: Case fatality and ACE2 inhibitors treatment concerns in patients with comorbidities Cord-id: ls61sn00 Document date: 2020_11_2
ID: ls61sn00
Snippet: The Corona Virus Disease 2019 (COVID-19) outbreak is becoming pandemic with the highest mortality in patients with associated comorbidities. These RNA viruses containing 4 structural proteins usually use spike protein to enter the host cell. Angiotensin-converting enzyme 2 (ACE2) acts as a host receptor for the virus. Therefore, medications acting on renin-angiotensin-aldosterone system can lead to serious complications, especially in patients with diabetes and hypertension. To avoid this, other
Document: The Corona Virus Disease 2019 (COVID-19) outbreak is becoming pandemic with the highest mortality in patients with associated comorbidities. These RNA viruses containing 4 structural proteins usually use spike protein to enter the host cell. Angiotensin-converting enzyme 2 (ACE2) acts as a host receptor for the virus. Therefore, medications acting on renin-angiotensin-aldosterone system can lead to serious complications, especially in patients with diabetes and hypertension. To avoid this, other potential treatment modalities should be used in COVID-19 patients with associated comorbidities.
Search related documents:
Co phrase search for related documents- abnormal activity and liver disease: 1, 2
- abnormal activity and lung disease: 1
- abnormal activity and lung injury: 1
- ace inhibitor and action mechanism: 1, 2, 3, 4
- ace inhibitor and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
- ace inhibitor and adaptive innate: 1
- ace inhibitor and adaptive innate immunity: 1
- ace inhibitor and lung damage: 1
- ace inhibitor and lung disease: 1
- ace inhibitor and lung injury: 1, 2, 3, 4
- action mechanism and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- action mechanism and adaptive innate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- action mechanism and adaptive innate immunity: 1, 2, 3, 4, 5
- action mechanism and liver disease: 1, 2, 3, 4
- action mechanism and lung damage: 1, 2, 3, 4, 5, 6
- action mechanism and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- action mechanism and lung disease heart: 1
- action mechanism and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
- action mechanism and lung injury development: 1
Co phrase search for related documents, hyperlinks ordered by date